Class information for:
Level 1: PROTEASOME INHIBITOR//BORTEZOMIB//PROTEASOME

Basic class information
Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY 2934640
203 3       AUTOPHAGY//HEAT SHOCK PROTEIN//PROTEASOME 52353
661 2             PROTEASOME//UBIQUITIN//SUMO 13805
5064 1                   PROTEASOME INHIBITOR//BORTEZOMIB//PROTEASOME 1709

Terms with highest relevance score


rank Category termType chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 PROTEASOME INHIBITOR authKW 1672252 17% 30% 298
2 BORTEZOMIB authKW 1316973 21% 20% 353
3 PROTEASOME authKW 349101 17% 7% 291
4 PROTEASOME INHIBITION authKW 287001 4% 26% 61
5 CARFILZOMIB authKW 254385 3% 32% 43
6 PS 341 authKW 249283 2% 52% 26
7 SYRBACTIN authKW 165959 1% 100% 9
8 MARIZOMIB authKW 156190 1% 71% 12
9 IMMUNOPROTEASOME authKW 115169 2% 18% 34
10 CEP 18770 authKW 94832 0% 86% 6

Web of Science journal categories


chi_square_rank Category chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 Oncology 8342 37% 0% 631
2 Chemistry, Medicinal 2463 12% 0% 202
3 Hematology 1656 10% 0% 173
4 Pharmacology & Pharmacy 729 14% 0% 244
5 Biochemistry & Molecular Biology 619 20% 0% 334
6 Cell Biology 461 10% 0% 176
7 Chemistry, Organic 214 7% 0% 114
8 Immunology 51 5% 0% 78
9 Medicine, Research & Experimental 44 3% 0% 54
10 Biophysics 14 2% 0% 38

Address terms


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 INTEGRATED PROT SCI 59070 2% 9% 35
2 LEHRSTUHL BIOCHEM 49739 2% 10% 27
3 ZENTRUM MED BIOTECHNOL 44597 1% 17% 14
4 BIOMETRY STAT ANAL 41488 0% 75% 3
5 MED STUDY PROGRAM 36880 0% 100% 2
6 JEROME LIPPER MYELOMA MED ONCOL 35455 0% 38% 5
7 FRED WYSZKOWSKI CANC 26326 1% 14% 10
8 JEROME LIPPER MULTIPLE MYELOMA 25574 1% 7% 20
9 EDUC DRUG DISCOVERY 25301 1% 15% 9
10 CHILDRENS CANC HOSP MD ANDERSON 24585 0% 67% 2

Journals


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 MOLECULAR CANCER THERAPEUTICS 6620 2% 1% 39
2 CLINICAL CANCER RESEARCH 2941 3% 0% 50
3 CHEMISTRY & BIOLOGY 1971 1% 1% 17
4 INVESTIGATIONAL NEW DRUGS 1573 1% 1% 15
5 CURRENT CANCER DRUG TARGETS 1471 1% 1% 9
6 JOURNAL OF MEDICINAL CHEMISTRY 1355 2% 0% 41
7 CANCER CHEMOTHERAPY AND PHARMACOLOGY 1262 1% 0% 23
8 CANCER BIOLOGY & THERAPY 1238 1% 0% 14
9 JOURNAL OF ANTIBIOTICS 1167 1% 0% 21
10 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 1135 2% 0% 41

Author Key Words


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass LCSH search Wikipedia search
1 PROTEASOME INHIBITOR 1672252 17% 30% 298 Search PROTEASOME+INHIBITOR Search PROTEASOME+INHIBITOR
2 BORTEZOMIB 1316973 21% 20% 353 Search BORTEZOMIB Search BORTEZOMIB
3 PROTEASOME 349101 17% 7% 291 Search PROTEASOME Search PROTEASOME
4 PROTEASOME INHIBITION 287001 4% 26% 61 Search PROTEASOME+INHIBITION Search PROTEASOME+INHIBITION
5 CARFILZOMIB 254385 3% 32% 43 Search CARFILZOMIB Search CARFILZOMIB
6 PS 341 249283 2% 52% 26 Search PS+341 Search PS+341
7 SYRBACTIN 165959 1% 100% 9 Search SYRBACTIN Search SYRBACTIN
8 MARIZOMIB 156190 1% 71% 12 Search MARIZOMIB Search MARIZOMIB
9 IMMUNOPROTEASOME 115169 2% 18% 34 Search IMMUNOPROTEASOME Search IMMUNOPROTEASOME
10 CEP 18770 94832 0% 86% 6 Search CEP+18770 Search CEP+18770

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.

Classes with closest relation at Level 1


rank cluster_id2 link
1 1011 PROTEASOME//MULTICATALYTIC PROTEINASE//20S PROTEASOME
2 21274 CONAGENIN//KAITOCEPHALIN//SALINOSPORAMIDE A
3 943 MULTIPLE MYELOMA//LENALIDOMIDE//BORTEZOMIB
4 32499 NELFINAVIR//SAQUINAVIR NO//FE EN MED
5 32416 PSMA6//ECCELLENZA CARDIOVASC//GERIATR INTEGRATED TRADIT WESTERN MED
6 30936 PUPYLATION//PROKARYOTIC UBIQUITIN LIKE PROTEIN//PAFA
7 24088 MOLECULAR MISREADING//SKIN BARRIER NETWORK HUMAN OURCES DEV TEAM BK2//DUAL HIT
8 28288 TRIPEPTIDYL PEPTIDASE II//TPPII//DALIS
9 36663 UBCH10//UBE2C//UBE2Q1
10 5609 MULTIPLE MYELOMA//MYELOMA BONE DISEASE//JEROME LIPPER MULTIPLE MYELOMA

Go to start page